Injective price maintains a bullish daily trend despite weakening short-term momentum.
Binance data show the Injective price at $7.97 on the live daily candle as of November 11, 2026, above all three daily EMAs. The bullish daily structure remains intact, but short-term momentum is working against it, framing a pullback within an uptrend rather than a confirmed bearish reversal.
Summary
Key takeaways
- INJ trades at $7.97 on the live daily candle, above all three daily EMAs.
- Hourly RSI is 47.2 and 15-minute RSI is 30.2, showing intraday pressure not yet confirmed on the daily chart.
- An hourly close above $8.08 would trigger a recovery setup, while an hourly close below $7.97 would favor a downside extension.
- The Fear & Greed Index stands at 29, classified as Fear.
- CoinGecko puts total crypto market capitalization at $2.45 trillion and Bitcoin dominance at 60.43%.
Injective price faces a daily-uptrend, intraday-pullback split
The daily EMA structure is bullishly aligned, giving the larger trend the benefit of the doubt. The hourly averages are also bullishly aligned, yet price trades below the hourly EMA20 and EMA50 and above the hourly EMA200. That distinction matters: the structure remains constructive, but current price action is no longer following its faster trend measures.
Meanwhile, the 15-minute chart is weaker. Price sits below all three EMAs, and those averages are not aligned. For execution context, this favors treating an intraday rebound as a recovery attempt rather than evidence that the daily advance has resumed.
Support is close, but volatility leaves room for false breaks
The daily EMA20 at $7.88 is the nearest daily trend support, followed by the daily EMA50 at $7.56 and daily EMA200 at $6.06. Price remains above each. The bullish bias therefore has a nearby test before the deeper trend measures become relevant.
On the hourly chart, the EMA200 at $7.96 sits just below price, while the EMA50 at $8.10 and EMA20 at $8.14 sit overhead. As a result, this compresses the immediate contest into support beneath the market and a recovery barrier above it; bullish alignment alone does not remove that barrier.
The daily Bollinger midpoint is $7.77, with the lower and upper bands at $6.96 and $8.59. Price remains above the midpoint, consistent with the constructive daily bias. On the hourly chart, price is below the $8.08 Bollinger midpoint, between the lower band at $7.72 and upper band at $8.45. The contrast supports a mean-reversion reading of the intraday weakness rather than an established daily breakdown.
The live 15-minute price is back above its lower Bollinger band at $7.93, whereas the last completed candle closed at $7.89. That is an early recovery in price location, not confirmation that momentum has turned.
ATR measures approximately $0.64 daily, $0.17 hourly and $0.08 on the 15-minute chart. Consequently, those readings put the narrow gap to nearby hourly support in perspective. A brief breach could fit within ordinary price movement rather than mark a durable change of trend.
RSI weakens intraday while MACD separates correction from reversal
Daily RSI is 53.0, modestly on the constructive side of neutral without signaling strong upside momentum. Hourly RSI has fallen to 47.2, while 15-minute RSI has declined to 30.2. The latter is approaching oversold territory, not yet oversold. Together, these readings show intraday pressure that the daily chart has not fully confirmed.
MACD reinforces that distinction. The daily histogram remains positive but is narrowing, indicating fading bullish momentum rather than a negative turn. The hourly histogram is also positive and narrowing, so its remaining upside momentum offers limited reassurance against the weaker RSI.
On the 15-minute chart, the histogram is negative and widening. That makes the live rebound vulnerable: price has improved relative to the lower Bollinger band, but completed-candle momentum still points the other way.
Hourly closes define the bullish recovery and bearish extension
The daily pivot at $7.97 lies marginally above the live daily price before rounding. It is an immediate reference, not an untested breakout threshold: the last completed daily candle already closed above it. The more useful pending test is the nearest hourly resistance.
Bullish scenario: an hourly close above the hourly Bollinger midpoint at $8.08 would trigger a recovery setup. The overhead EMA barriers would still need to be absorbed, with the hourly pivot at $8.13, hourly R1 at $8.22 and daily R1 at $8.29 defining further resistance. An hourly close below hourly S1 at $7.97 would invalidate this recovery scenario. The likeliest false signal is a rebound through the midpoint that stalls within the overhead averages while short-term MACD remains negative.
Bearish scenario: an hourly close below hourly S1 at $7.97 would trigger a downside extension setup. A move through the nearby hourly EMA200 would expose the daily EMA20, followed by the daily Bollinger midpoint and daily S1 at $7.70. An hourly close back above the hourly Bollinger midpoint at $8.08 would invalidate that setup. Its main false-signal risk is a brief support break that reverses while the daily trend remains intact and 15-minute RSI is near the oversold threshold.
ETF context and uneven DEX activity do not confirm a breakout
Canary’s Injective ETF debuted on Nasdaq on November 5, 2026, with exposure to staking rewards. That provides institutional-product context, but the supplied price data do not establish that the debut caused the current move or overcame the intraday technical weakness.
Chain-wide records $1,367,544.02 in chain-wide DEX trading volume over 24 hours on Injective. These are blockchain-wide trading volumes, not INJ-specific turnover, fees or revenue. Choice Exchange V2 reports a daily volume increase of 94.83%, while Injective Spot reports 59.51%; their 30-day changes are negative at 46.13% and 70.5%, respectively. The picture is therefore mixed across measurement windows, not evidence of uniform expansion in activity.
Fear frames a cautious backdrop for the daily bullish bias
Alternative.me’s Fear & Greed Index stands at 29, classified as Fear. Meanwhile, CoinGecko places total crypto market capitalization at $2.45 trillion and Bitcoin dominance at 60.43%. These are backdrop readings, not proof of a cause for INJ’s pullback. In this setting, the daily bullish structure has more credibility than an assumption of broad risk appetite.
FAQ
Is Injective already oversold?
No. The supplied 15-minute RSI is 30.2, approaching the oversold threshold, while the hourly and daily readings remain above it.
Do the DEX figures measure INJ trading alone?
No. They cover trading activity on the Injective blockchain and should not be read as asset-specific turnover or revenue.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.
